Having worked with huge companies like Swisse Wellness and L'Oreal, Oliver Horn brings a wealth of experience to Elixinol Global (ASX:EXL) and sits down for an episode of the CannaCast to discuss the company's future.
Elixinol Global (ASX:EXL) is a global leader in the CBD-derived hemp industry, with operations throughout Asia Pacific, Europe, and the Americas. In Australia, you can find Elixinol's products under the banner of Hemp Foods Australia, a wholly-owned EXL subsidiary that produces hemp oils, soups, spreads, skincare, and protein powders.
To learn more about Elixinol, we sat down with the company's CEO Oliver Horn, and chatted all things hemp, COVID-19, whether the eventual big pharma takeover of the cannabis industry was a good or bad thing, and if it can be avoided, as well as Elixinol's recent acquisition of German-based CannaCare Health, one of Germany's leading CBD brands with a dominant share of distribution in Germany's drugstore channels.
"Our investment focuses really lie in Europe and the U.S., which is where we're driving our CBD agenda really hard because we have a really embedded brand. The majority of our business is in Colorado, we've been there for around seven years now, and we have manufacturing packaging and production there. We supply almost the entirety of the Americas including the Latin Americas, and it's really our cornerstone of operations."
In this episode of the CannaCast, we also discussed Australia's change in the scheduling of CBD medicines from Schedule 4 to Schedule 3 and why Oliver remains dissatisfied with this change.
We hope you enjoy this informative episode of The CannaCast with Elixinol Global's Oliver Horn!
This episode was produced by Casey Peternell, the introduction theme music was created by Reni Mathason and the CannaCast image was created by Niccole Lim. You can find the episode on our Spotify as well as on Apple Podcasts.
Get the Latest Marijuana News &
Content in your Inbox!
All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors